Subcutaneous chromoblastomycosis occurring in a patient with systemic lupus erythematosus.
D000328:Adult; D002862:Chromoblastomycosis / Q000139:chemically induced*; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D011241:Prednisone / Q000009:adverse effects*
D003520:Cyclophosphamide; D011241:Prednisone